The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 6 December 2004. doi:10.1084/jem.20041575
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 200, Number 11, 1467-1478
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 890K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J. Q.
Right arrow Articles by Davidson, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J. Q.
Right arrow Articles by Davidson, W. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl

Jian Qiao Zhang1, Cheryl Okumura2,3, Thomas McCarty2,4, Min Sun Shin2, Partha Mukhopadhyay1, Mitsuo Hori2,5, Ted A. Torrey2, Zohreh Naghashfar2, Jeff X. Zhou2, Chang Hoon Lee2, Derry C. Roopenian6, Herbert C. Morse, III2, and Wendy F. Davidson1,7

1 Department of Immunology, Holland Laboratory, American Red Cross, Rockville, MD 20855
2 Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD 20852
3 University of California, Los Angeles, Los Angeles, CA 90095
4 Translational Genomics, Gaithersburg, MD 20878
5 Ibaraki Prefectural Central Hospital, Ibaraki 310-0815, Japan
6 The Jackson Laboratory, Bar Harbor, ME 04609
7 Department of Immunology, Institute for Biological Sciences, George Washington University, Washington, DC 20037

Address correspondence to Wendy F. Davidson, Greenebaum Cancer Center and Dept. of Microbiology and Immunology, University of Maryland School of Medicine, 15601 Crabbs Branch Way, Rockville, MD 20855. Phone: (301) 517-0324; Fax: (301) 517-0344; email: wdavi002{at}umaryland.edu

Germline mutations in Fas and Fasl induce nonmalignant T cell hyperplasia and systemic autoimmunity and also greatly increase the risk of B cell neoplasms. B lymphomas occurring in Fasl mutant (gld) mice usually are immunoglobulin (Ig) isotype switched, secrete Ig, and are plasmacytoid in appearance but lack Myc translocations characteristic of other plasma cell (PC) neoplasms. Here, we explore the relationship between B cell autoreactivity and transformation and use gene expression profiling to further classify gld plasmacytoid lymphomas (PLs) and to identify genes of potential importance in transformation. We found that the majority of PLs derive from antigen-experienced autoreactive B cells producing antinuclear antibody or rheumatoid factor and exhibit the skewed Ig V gene repertoire and Ig gene rearrangement patterns associated with these specificities. Gene expression profiling revealed that both primary and transplanted PLs share a transcriptional profile that places them at an early stage in PC differentiation and distinguishes them from other B cell neoplasms. In addition, genes were identified whose altered expression might be relevant in lymphomagenesis. Our findings provide a strong case for targeted transformation of autoreactive B cells in gld mice and establish a valuable model for understanding the relationship between systemic autoimmunity and B cell neoplasia.

Key Words: autoimmunity • B cell lymphoma


J.Q. Zhang and C. Okumura contributed equally to this work.

Abbreviations used in this paper: ANA, antinuclear antibody; BCR, B cell receptor; BL, Burkitt lymphoma; BLL, Burkitt-like lymphoma; CBL, centroblastic; CDR, complementarity-determining region; CL, cardiolipin; dsDNA, double-stranded DNA; FBL, follicular B cell lymphoma; FWR, framework region; GC, germinal center; GL, germline; IBL, immunoblastic; MALT, mucosal-associated lymphoid tissue; MZL, splenic marginal zone lymphoma; PC, plasma cell; PCA, principal component analysis; PCT, plasmacytoma; PL, plasmacytoid lymphoma; PPC, phosphorylcholine; R mutation, replacement mutation; RF, rheumatoid factor; S mutation, silent mutation; SBL, small B cell lymphoma; SJL, SJL-ß2M–/– lymphoma; ssDNA, single-stranded DNA.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS